Publicador de contenidos

Investigación, Resistencia antimicrobiana

SAFE (Superbug Awareness For Education) - 2nd Edition

Antimicrobial Resistances

SAFE 2a Edición
Duración
01/01/2021 - 31/12/2021
Coordinador
Clara Ballesté
Financiadores
EIT Health

SAFE organises Service Learning workshops for university and secondary school students in countries in southern Europe—the European region with the most serious bacterial resistance problem.

The addition of new consortium members will extend the project piloted last year in Spain and Italy to include Portugal in 2021. In addition, with the objective of promoting knowledge of infectious diseases in all sectors of society, the target audience will be extended to encompass students, teachers, health professionals, and patients.

SAFE II (#EIThealthSAFE) will offer an online course based on the Service Learning approach to primary and secondary school teachers and provide outreach and gamification resources designed to facilitate the transfer of knowledge about antimicrobial resistance. The aim is to reach students in all communities and at all levels of education and to extend the outreach to society in general.

SAFE II will also train health professionals in outreach strategies to raise awareness in the general population about antimicrobial resistance.

Total Funding

102,944.00 euros

Funder

Nuestro equipo

Coordinator

ISGlobal Team

Otros proyectos

Ver proyectos pasados

COMBACTE

Combatiendo la Resistencia Bacteriana en Europa

GAMA

Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting

COMBACTE-CARE

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

INTE-AFRICA

Integrating and decentralizing diabetes and hypertension services in Africa

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

PreFIT

Predicting the Future: Incipient Tuberculosis

ANTICOV

Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19

Stool4TB

Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV

TB-RECONNECT

Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status

SToolNIH

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring

END-VOC

ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

ENDÈMIC

Community knowledge generation through scientific culture, urban ecology and art

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.

FLAVOBAC

Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias